4-(3,ethylchloro3-methyltriaz-1-ene)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide

ID: ALA113534

PubChem CID: 44340703

Max Phase: Preclinical

Molecular Formula: C26H25ClN8O

Molecular Weight: 500.99

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)c2ccc(/N=N/N(C)CCCl)cc2)cc1Nc1nccc(-c2cccnc2)n1

Standard InChI:  InChI=1S/C26H25ClN8O/c1-18-5-8-22(30-25(36)19-6-9-21(10-7-19)33-34-35(2)15-12-27)16-24(18)32-26-29-14-11-23(31-26)20-4-3-13-28-17-20/h3-11,13-14,16-17H,12,15H2,1-2H3,(H,30,36)(H,29,31,32)/b34-33+

Standard InChI Key:  AUHKMKATZQLPOZ-JEIPZWNWSA-N

Molfile:  

     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
    5.8292   -2.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8292   -3.6042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4167   -1.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5542    0.9708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2667   -2.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5500   -2.3542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4250   -2.3417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1125   -4.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5500    0.1458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9792   -2.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1125   -2.3667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7042   -1.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7042   -2.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1125   -4.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2750   -3.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1292   -1.1042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8417    1.3958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8250   -6.0917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9875   -1.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7042   -0.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2667   -0.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9875   -4.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4000   -3.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4000   -2.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7125   -3.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9917    0.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2667   -1.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8417    2.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8250   -5.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5625    3.4583    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.3917   -5.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1125   -6.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5625    2.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5542   -4.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1292    0.9833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3917   -6.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  7  1  0
  4  9  2  0
  5  6  1  0
  6  1  1  0
  7 13  1  0
  8  2  2  0
  9 21  1  0
 10  5  1  0
 11  1  2  0
 12  3  1  0
 13 10  2  0
 14  8  1  0
 15  5  2  0
 16  3  2  0
 17  4  1  0
 18 29  2  0
 19 12  1  0
 20 12  2  0
 21 26  2  0
 22 15  1  0
 23 24  2  0
 24 11  1  0
 25 22  2  0
 26 20  1  0
 27 19  2  0
 28 17  1  0
 29 14  1  0
 30 33  1  0
 31 14  2  0
 32 36  2  0
 33 28  1  0
 34 15  1  0
 35 17  1  0
 36 31  1  0
 23  8  1  0
 25 13  1  0
 32 18  1  0
 27 21  1  0
M  END

Associated Targets(Human)

ABL1 Tclin Tyrosine-protein kinase ABL (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 500.99Molecular Weight (Monoisotopic): 500.1840AlogP: 6.01#Rotatable Bonds: 9
Polar Surface Area: 107.76Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.69CX Basic pKa: 4.26CX LogP: 5.65CX LogD: 5.65
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.17Np Likeness Score: -1.62

References

1. Rachid Z, Katsoulas A, Brahimi F, Jean-Claude BJ..  (2003)  Synthesis of pyrimidinopyridine-triazene conjugates targeted to abl tyrosine kinase.,  13  (19): [PMID:12951113] [10.1016/s0960-894x(03)00553-5]
2. Cui J, Fu R, Zhou LH, Chen SP, Li GW, Qian SX, Liu S..  (2013)  BCR-ABL tyrosine kinase inhibitor pharmacophore model derived from a series of phenylaminopyrimidine-based (PAP) derivatives.,  23  (8): [PMID:23473682] [10.1016/j.bmcl.2013.01.113]

Source